Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8738279 | Immunology Letters | 2018 | 27 Pages |
Abstract
CD8+CD28â regulatory T cells (Tregs) play important roles in chronic viral infections. Programmed death 1 (PD-1) is highly expressed on hepatitis C virus (HCV)-specific CTLs. However, little is known regarding the role of CD8+CD28-PD1+ T cells in hepatitis C. Herein, we found that the frequency of CD8+CD28âPD1+, but not CD8+CD28âPD1â T cells, correlated with markers of chronic hepatitis C virus (HCV) infection and the response to treatment. Our results showed that CD8+CD28-PD1+ T cells were significantly elevated in chronic HCV-infected patients and there was a distinct correlation between the frequency of CD8+CD28-PD1+ T cells and serum levels of HCV RNA. During a 48-week course of treatment with peg-IFN-a2a plus ribavirin, dynamic changes in the frequencies of CD8+CD28-PD1+ T cells were observed, associated with the virologic response. IL-10 secretion may explain the suppressive function of CD8+CD28-PD1+ T cells in chronic HCV-infected patients. Overall, our study demonstrates that PD-1 is an important marker of CD8+CD28â Tregs in chronic HCV infection. Thus, the frequency and regulatory function of CD8+CD28-PD1+ T cells play vital roles in HCV infection and the response to treatment.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Weihong Wang, Zhaowei Tong, Jianfeng Zhong, Longqi Zhang, Hui Zhang, Yanguang Su, Bingbing Gao, Chun Zhang,